AMERICAN REBEL HOLDINGS INC (AREB): Nasdaq/NYSE listing notice — American Rebel receives Nasdaq deficiency notice for audit committee; appoints new independent director
AMERICAN REBEL HOLDINGS INC
Ken Yonika resigned as director and audit committee member on April 4, 2023, reducing the committee to two members.
On May 9, 2023, Nasdaq notified non-compliance with Rule 5605(c)(2)(A) requiring at least three independent audit committee members.
Cure period extends to the earlier of the next annual shareholder meeting or April 4, 2024 (or Oct 2, 2023 if meeting before then).
Board appointed C. Stephen Cochennet as independent director and audit committee member effective May 9, 2023, restoring compliance.
Cochennet also joins the compensation, nominating & governance, and mergers & acquisitions committees.
AMERICAN REBEL HOLDINGS INC received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)(A), 5605(c)(4)).
Exchange
nasdaq
Notice
deficiency notice
Deficiency
audit committee
Rules
5605(c)(2)(A), 5605(c)(4)
Exact text from the filing
May 9, 2023, the Registrant received correspondence from Nasdaq noting that the Registrant was no longer in compliance with Nasdaq’s audit committee composition requirements as set forth in Nasdaq Listing Rule 5605 (the “Notice”). The Notice also stated, among other things, that, pursuant to Nasdaq Listing Rule 5605(c)(4), the Registrant is entitled to a cure period in order to regain compliance with Nasdaq Listing Rule 5605(c)(2)(A), which cure period will expire upon (i) the earlier of either the date of the Registrant ‘s next annual shareholders’ meeting or April 4, 2024, or (ii) if the nex
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.